Propacetamol Showed Therapeutic Equivalence for Sulpyrine

Published: 2004-12-03 06:54:00

Updated: 2004-12-03 06:54:00

Following the KFDA’s ban on the production and sales of drugs containing terfenadine and sulpyrine due to possible harmful side effects, a recent report from the overseas clinical studies is drawing attention on the therapeutic equivalence of Propacetamol with the banned Sulpyrine.

The studies...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK